Article Information
vol. 47 no. 6 1776-1784
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 10, 2015
- Accepted January 25, 2016
- Published online May 31, 2016.
Article Versions
- previous version (April 21, 2016 - 00:00).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©ERS 2016
Author Information
- Michael Kreuter1⇑,
- Marlies S. Wijsenbeek2,
- Martina Vasakova3,
- Paolo Spagnolo4,
- Martin Kolb5,
- Ulrich Costabel6,
- Derek Weycker7,
- Klaus-Uwe Kirchgaessler8 and
- Toby M. Maher9
- 1Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg (TLRCH), Heidelberg, Germany; Member of the German Center for Lung Research (DZL), Germany
- 2Dept of Pulmonary Medicine, Erasmus Medical Center, University Hospital Rotterdam, Rotterdam, The Netherlands
- 3Dept of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic
- 4Medical University Clinic, Canton Hospital Baselland and University of Basel, Liestal, Switzerland
- 5Firestone Institute for Respiratory Health, Dept of Medicine, Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
- 6Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany
- 7Policy Analysis Inc. (PAI), Brookline, MA, USA
- 8F. Hoffmann-La Roche Ltd, Basel, Switzerland
- 9National Institute for Health Research Biomedical Research Unit, Royal Brompton Hospital and Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK
- Michael Kreuter, Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, Heidelberg University Hospital, Röntgenstrasse 1, 69120 Heidelberg, Germany. E-mail: kreuter{at}uni-heidelberg.de
Funding
F. Hoffman-La Roche
Article usage
Altmetrics
Vol 47 Issue 6
Table of Contents
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis
